108 related articles for article (PubMed ID: 26352355)
1. Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients.
Avemaria F; Carrera P; Lapolla A; Sartore G; Chilelli NC; Paleari R; Ambrosi A; Ferrari M; Mosca A
Clin Chem Lab Med; 2015 Aug; 53(9):1315-20. PubMed ID: 26352355
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic repair of Amadori products.
Van Schaftingen E; Collard F; Wiame E; Veiga-da-Cunha M
Amino Acids; 2012 Apr; 42(4):1143-50. PubMed ID: 20967558
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
4. Fructosamine-6-phosphates are deglycated by phosphorylation to fructosamine-3,6-bisphosphates catalyzed by fructosamine-3-kinase (FN3K) and/or fructosamine-3-kinase-related-protein (FN3KRP).
Szwergold BS
Med Hypotheses; 2007; 68(1):37-45. PubMed ID: 16920277
[TBL] [Abstract][Full Text] [Related]
5. Increased protein glycation in fructosamine 3-kinase-deficient mice.
Veiga da-Cunha M; Jacquemin P; Delpierre G; Godfraind C; Théate I; Vertommen D; Clotman F; Lemaigre F; Devuyst O; Van Schaftingen E
Biochem J; 2006 Oct; 399(2):257-64. PubMed ID: 16819943
[TBL] [Abstract][Full Text] [Related]
6. A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines.
Collard F; Delpierre G; Stroobant V; Matthijs G; Van Schaftingen E
Diabetes; 2003 Dec; 52(12):2888-95. PubMed ID: 14633848
[TBL] [Abstract][Full Text] [Related]
7. The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein appears to be constitutive and unaffected by environmental signals.
Conner JR; Beisswenger PJ; Szwergold BS
Biochem Biophys Res Commun; 2004 Oct; 323(3):932-6. PubMed ID: 15381090
[TBL] [Abstract][Full Text] [Related]
8. A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines.
Szwergold B
Rejuvenation Res; 2021 Aug; 24(4):310-318. PubMed ID: 34314247
[TBL] [Abstract][Full Text] [Related]
9. Fructosamine 3-kinase, an enzyme involved in protein deglycation.
Delpierre G; Van Schaftingen E
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1354-7. PubMed ID: 14641062
[TBL] [Abstract][Full Text] [Related]
10. Fructosamine-3-kinase-related-protein phosphorylates glucitolamines on the C-4 hydroxyl: novel substrate specificity of an enigmatic enzyme.
Szwergold B; Manevich Y; Payne L; Loomes K
Biochem Biophys Res Commun; 2007 Oct; 361(4):870-5. PubMed ID: 17686456
[TBL] [Abstract][Full Text] [Related]
11. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo.
Szwergold BS; Howell S; Beisswenger PJ
Diabetes; 2001 Sep; 50(9):2139-47. PubMed ID: 11522682
[TBL] [Abstract][Full Text] [Related]
12. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
Delpierre G; Veiga-da-Cunha M; Vertommen D; Buysschaert M; Van Schaftingen E
Diabetes Metab; 2006 Feb; 32(1):31-9. PubMed ID: 16523184
[TBL] [Abstract][Full Text] [Related]
13. Genetic variability of the fructosamine 3-kinase gene in diabetic patients.
Mosca L; Penco S; Patrosso MC; Marocchi A; Lapolla A; Sartore G; Chilelli NC; Paleari R; Mosca A
Clin Chem Lab Med; 2011 May; 49(5):803-8. PubMed ID: 21288167
[TBL] [Abstract][Full Text] [Related]
14. The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging.
Monnier VM
Biochem J; 2006 Oct; 399(2):e11-3. PubMed ID: 16987105
[TBL] [Abstract][Full Text] [Related]
15. Plant ribulosamine/erythrulosamine 3-kinase, a putative protein-repair enzyme.
Fortpied J; Gemayel R; Stroobant V; van Schaftingen E
Biochem J; 2005 Jun; 388(Pt 3):795-802. PubMed ID: 15705060
[TBL] [Abstract][Full Text] [Related]
16. Fructosamine 3-kinase-related protein and deglycation in human erythrocytes.
Collard F; Wiame E; Bergans N; Fortpied J; Vertommen D; Vanstapel F; Delpierre G; Van Schaftingen E
Biochem J; 2004 Aug; 382(Pt 1):137-43. PubMed ID: 15137908
[TBL] [Abstract][Full Text] [Related]
17. Evidence That Differences in Fructosamine-3-Kinase Activity May Be Associated With the Glycation Gap in Human Diabetes.
Dunmore SJ; Al-Derawi AS; Nayak AU; Narshi A; Nevill AM; Hellwig A; Majebi A; Kirkham P; Brown JE; Singh BM
Diabetes; 2018 Jan; 67(1):131-136. PubMed ID: 29066600
[TBL] [Abstract][Full Text] [Related]
18. Many fructosamine 3-kinase homologues in bacteria are ribulosamine/erythrulosamine 3-kinases potentially involved in protein deglycation.
Gemayel R; Fortpied J; Rzem R; Vertommen D; Veiga-da-Cunha M; Van Schaftingen E
FEBS J; 2007 Sep; 274(17):4360-74. PubMed ID: 17681011
[TBL] [Abstract][Full Text] [Related]
19. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.
Conner JR; Beisswenger PJ; Szwergold BS
Ann N Y Acad Sci; 2005 Jun; 1043():824-36. PubMed ID: 16037310
[TBL] [Abstract][Full Text] [Related]
20. Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM.
Sartore G; Ragazzi E; Burlina S; Paleari R; Chilelli NC; Mosca A; Avemaria F; Lapolla A
BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32467223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
